- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02412995
The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite (OPUS-WP3C)
The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite - A Randomised, Controlled, Crossover Study of Danish Berries in Overweight and Obese Male Subjects
Study Overview
Status
Conditions
Detailed Description
Purpose: Berries and mixed berry products exert acute effects on postprandial glycaemia and insulinemia, but very few berries have been studied, and primarily in normal weight subjects. Sea buckthorn and strawberry are compositionally widely different berries and may likely produce different responses. The effects of strawberry and sea buckthorn on postprandial glycaemia and insulinemia were examined in overweight or obese male subjects. Subjective appetite sensations and ad libitum intake were also examined. Berries may thus improve health in longer studies; however, accurate assessment of berry intake is still problematic. The discovery of objective biomarkers for intake of berries is therefore important in assessing both intake and compliance. The investigators aimed to identify urinary exposure markers of two very different berries, strawberry and sea buckthorn, in humans.
Methods: The study was conducted as a randomised, controlled, single-blinded, 3-way crossover study. Eighteen subjects were studied in three 2 h meal tests followed by a subsequent ad libitum meal. Test meals contained either sea buckthorn, strawberry or no berries and added sucrose to match with respect to sucrose content. Blood samples were collected at t = 0, 30, 45, 60, 90 and 120 min. Subjective appetite sensations were recorded at t = 0, 15, 30, 45, 60, 90, 120 and 140 min and subsequent ad libitum intake was recorded. Statistical differences in all continuous measures were evaluated based on the existence of a meal or a time-meal interaction by repeated measurements analyses or differences in the area under the curve (AUC) for that measure in a linear mixed model. Urine samples were collected on each test day at t=-15min, t=0-1h, t=1-2h, and t=2-24h and were analyzed by untargeted metabolomics. Multivariate analysis was applied to discover markers, followed by molecular fragmentation to ease their chemical identification.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
-
Frederiksberg C, Denmark, 1958
- Department of Nutrition, Exercise and Sports, University of Copenhagen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy, male, aged 20-50 years and body mass index (BMI) 25-35 kg/m2
Exclusion Criteria:
- Any current or chronic clinical conditions
- Chronic/frequent use of medication
- Smoking
- Blood donation
- High level of strenuous physical activity (>10h/week)
- High habitual alcohol consumption (>14 drinks/week)
- Present or previous drug abuse
- Participation in other human intervention studies, and obesity surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Meal sequence 1-2-3
The three meals, sea buckthorn puree, strawberry puree, or placebo (sugar drink) were allocated a number (1-3) in a blinded fashion and given to the participants in the order 1-2-3
|
The subjects were studied in three 2 h meal tests with a subsequent ad libitum meal on separate days, at least two days apart.
The subjects were individually randomised to the sequence of the test meals using random permutation.
The study included two berry meals based on 150 g of frozen berries; sea buckthorn (Hippophaë rhamnoides) and strawberry (Fragaria x ananassa), respectively, and one control meal which did not contain berries.
Each meal contained 35 g of sucrose and was adjusted for protein and fat with whey protein and canola oil, respectively.
The meals were served with 120 mL of water.
|
Experimental: Meal sequence 1-3-2
The three meals, sea buckthorn puree, strawberry puree, or placebo (sugar drink) were allocated a number (1-3) in a blinded fashion and given to the participants in the order 1-3-2
|
The subjects were studied in three 2 h meal tests with a subsequent ad libitum meal on separate days, at least two days apart.
The subjects were individually randomised to the sequence of the test meals using random permutation.
The study included two berry meals based on 150 g of frozen berries; sea buckthorn (Hippophaë rhamnoides) and strawberry (Fragaria x ananassa), respectively, and one control meal which did not contain berries.
Each meal contained 35 g of sucrose and was adjusted for protein and fat with whey protein and canola oil, respectively.
The meals were served with 120 mL of water.
|
Experimental: Meal sequence 2-3-1
The three meals, sea buckthorn puree, strawberry puree, or placebo (sugar drink) were allocated a number (1-3) in a blinded fashion and given to the participants in the order 2-3-1
|
The subjects were studied in three 2 h meal tests with a subsequent ad libitum meal on separate days, at least two days apart.
The subjects were individually randomised to the sequence of the test meals using random permutation.
The study included two berry meals based on 150 g of frozen berries; sea buckthorn (Hippophaë rhamnoides) and strawberry (Fragaria x ananassa), respectively, and one control meal which did not contain berries.
Each meal contained 35 g of sucrose and was adjusted for protein and fat with whey protein and canola oil, respectively.
The meals were served with 120 mL of water.
|
Experimental: Meal sequence 2-1-3
The three meals, sea buckthorn puree, strawberry puree, or placebo (sugar drink) were allocated a number (1-3) in a blinded fashion and given to the participants in the order 2-1-3
|
The subjects were studied in three 2 h meal tests with a subsequent ad libitum meal on separate days, at least two days apart.
The subjects were individually randomised to the sequence of the test meals using random permutation.
The study included two berry meals based on 150 g of frozen berries; sea buckthorn (Hippophaë rhamnoides) and strawberry (Fragaria x ananassa), respectively, and one control meal which did not contain berries.
Each meal contained 35 g of sucrose and was adjusted for protein and fat with whey protein and canola oil, respectively.
The meals were served with 120 mL of water.
|
Experimental: Meal sequence 3-1-2
The three meals, sea buckthorn puree, strawberry puree, or placebo (sugar drink) were allocated a number (1-3) in a blinded fashion and given to the participants in the order 3-1-2
|
The subjects were studied in three 2 h meal tests with a subsequent ad libitum meal on separate days, at least two days apart.
The subjects were individually randomised to the sequence of the test meals using random permutation.
The study included two berry meals based on 150 g of frozen berries; sea buckthorn (Hippophaë rhamnoides) and strawberry (Fragaria x ananassa), respectively, and one control meal which did not contain berries.
Each meal contained 35 g of sucrose and was adjusted for protein and fat with whey protein and canola oil, respectively.
The meals were served with 120 mL of water.
|
Experimental: Meal sequence 3-2-1
The three meals, sea buckthorn puree, strawberry puree, or placebo (sugar drink) were allocated a number (1-3) in a blinded fashion and given to the participants in the order 3-2-1
|
The subjects were studied in three 2 h meal tests with a subsequent ad libitum meal on separate days, at least two days apart.
The subjects were individually randomised to the sequence of the test meals using random permutation.
The study included two berry meals based on 150 g of frozen berries; sea buckthorn (Hippophaë rhamnoides) and strawberry (Fragaria x ananassa), respectively, and one control meal which did not contain berries.
Each meal contained 35 g of sucrose and was adjusted for protein and fat with whey protein and canola oil, respectively.
The meals were served with 120 mL of water.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemia Area under the plasma glucose concentration curve, concentration curve.
Time Frame: postprandially 0-120min
|
Area under the plasma glucose concentration curve, concentration curve.
|
postprandially 0-120min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insulin response Area under the plasma insulin concentration curve
Time Frame: postprandially 0-120min
|
Area under the plasma insulin concentration curve
|
postprandially 0-120min
|
Appetite scores (visual analogue scale)
Time Frame: postprandially 0-140min
|
Measured on a 100 mm visual analogue scale spanning the sensation from minimum to maximum on the following: hunger, satiety, fullness, perceived prospective food intake, thirst, well-being, and desire for something sweet.
|
postprandially 0-140min
|
urine metabolic profile
Time Frame: 0-24 hrs
|
Urine samples were collected on each test day at t=-15min, t=0-1h, t=1-2h, and t=2-24h and were analyzed by untargeted metabolomics (UPLC-QTOF)
|
0-24 hrs
|
plasma metabolic profile (metabolic profiling by UPLC-QTOF)
Time Frame: 0-120min
|
Blood samples were drawn at t = -20 (baseline), 30, 45, 60, 90 and 120 min on each test day and subjected to untargeted metabolic profiling by UPLC-QTOF
|
0-120min
|
Meal perception VAS questionnaire
Time Frame: postprandially at 30min and 140 min
|
A VAS questionnaire concerning meal perception with ratings for taste (poor/good), smell (not appetising/appetising), appearance (not appetising/appetising), undertaste (none/much), and overall impression (not appetising/appetising).
|
postprandially at 30min and 140 min
|
Incremental area under the plasma glucose concentration curve
Time Frame: postprandially, 0-30 and 0-60min
|
The area under the initial part of the glucose plasma curve from the volunteer has ingested the sugar solution until 60 min later
|
postprandially, 0-30 and 0-60min
|
Glycemic profile (calculated as the time in minutes during which the blood glucose concentration is above baseline concentration divided by the incremental peak value of blood glucose)
Time Frame: 0-120 min
|
Gycemic profile((calculated as the time in minutes during which the blood glucose concentration is above baseline concentration divided by the incremental peak value of blood glucose)
|
0-120 min
|
Incremental insulin response Incremental area under the plasma insulin concentration curve.
Time Frame: Postprandially 0-30 and 0-60 min
|
Incremental area under the plasma insulin concentration curve.
|
Postprandially 0-30 and 0-60 min
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lars O Dragsted, Ph.D., University of Copenhagen
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M208
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Intolerance
-
Yonsei UniversityNot yet recruitingType 2 Diabetes | Impaired Glucose Intolerance
-
University of California, IrvineUniversity of California, Davis; University of California, San FranciscoCompletedStress, Psychological | Pregnancy Related | Glucose Intolerance During PregnancyUnited States
-
Arizona State UniversityRecruiting
-
University of SaskatchewanRoyal University Hospital FoundationCompletedGlucose IntoleranceCanada
-
Glycemic Index Laboratories, IncDSM Nutritional Products, Inc.Completed
-
Materia Medica HoldingCompletedImpaired Glucose ToleranceRussian Federation
-
Joslin Diabetes CenterCompleted
-
TakedaCompletedImpaired Glucose ToleranceJapan
-
China Academy of Chinese Medical SciencesUnknownImpaired Glucose Tolerance
-
University of TromsoCompleted
Clinical Trials on Meal sequence 1-2-3
-
Centre Hospitalier Universitaire DijonRecruiting
-
University of Colorado, DenverJohnson & JohnsonCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Yuhan CorporationCompletedHealthyKorea, Republic of
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Diabetes MellitusSingapore
-
University of CopenhagenCompletedBiomarkers of Food Intake in Healthy Subjects
-
Samyang Biopharmaceuticals CorporationCompletedHyperlipidemiaKorea, Republic of
-
University of NottinghamUnilever R&DCompleted
-
LG Life SciencesCompletedHypertension, HyperlipidemiaKorea, Republic of
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedHealthy VolunteersUnited States